The Drug Safety Research Unit (DSRU) is an independent academic unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training Services for over 30 years.
In partnership with doctors in England, the DSRU, led by Director Professor Saad Shakir, aims to protect patients in primary and specialist care from unwanted adverse effects of newly marketed medicines using our unique methods of monitoring patients during the lifecycle of medicines.
Following the outcome of the EU referendum, we would like to reassure you that the DSRU will continue to work on pharmacovigilance (PV) in Europe now and for many years to come. We continue to provide advice and conduct studies for risk management, risk minimisation and monitoring effectiveness of risk minimisation in Europe.
We also remain as ever committed to EU PV education. We continue to offer our highly-regarded short training courses, masterclasses, conferences and postgraduate programme in Pharmacovigilance.
As always we are happy to discuss issues, respond to questions and provide advice.
Please do not hesitate to contact us.
Also see Saad Shakir’s latest blog.View our latest news
The Drug Safety Research Unit (DSRU) offers a range of Pharmacovigilance (PV) training courses suitable for those looking for a career in pharmacovigilance, seeking career progression or in a position that requires PV knowledge and understanding. Depending on specific interests and current knowledge, the team at the DSRU is able to recommend which of our training courses could help […]View all our latest questions